Hepatitis C Treatment for Drug Users
The stigma surrounding addiction may discourage Hepatitis C treatment for drug users - but the evidence encourages these individuals to do triple therapy.
Continue reading »The stigma surrounding addiction may discourage Hepatitis C treatment for drug users - but the evidence encourages these individuals to do triple therapy.
Continue reading »The individual who first identified the Hepatitis C virus might be the same person responsible for ending its infectious reign.
Continue reading »By delivering genetic material to initiate a T cell response, Okairos is looking to create the first Hepatitis C preventative vaccine.
Continue reading »Boasting the world's highest rate of Hepatitis C, Egypt has a lot to gain from the American University in Cairo's fast and inexpensive Hepatitis C test.
Continue reading »In two separate Phase 3 trials, Hepatitis C patients with genotypes 1 and 4 are being treated with TMC435 plus pegylated interferon and ribavirin.
Continue reading »A six-year-old with a rare, fatal illness gets a second chance at life from a triple organ transplant, including a new liver.
Continue reading »Britain's National Institute for Health and Clinical Excellence officially recognizes that boceprevir's addition to the previous Hepatitis C treatment protocol dramatically improves this illness's cure rate.
Continue reading »Representing a potential treatment strategy for chronic liver disease, British scientists have been able to affect the production of new liver cells to heal liver damage.
Continue reading »In addition to carrying the IL28B gene, Spanish researchers have found that in HIV co-infected patients, a subtype of Hepatitis C genotype 1 fares better than another.
Continue reading »If you are taking Victrelis or Incivek to treat Hepatitis C, make sure you are aware of what cholesterol-lowering drugs should be avoided.
Continue reading »You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window